Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence (Q84278641)
Jump to navigation
Jump to search
scientific article published on 31 May 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence |
scientific article published on 31 May 2012 |
Statements
Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence (English)
Juping Zhao
Yu Zhu
Chongyu Zhang
Xiaojing Wang
Hongchao He
Haofei Wang
Yuxuan Wu
Wenlong Zhou
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference